Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication.
about
Macrophages and cytokines in the early defence against herpes simplex virusInhibition of Cellular 2'-5' Oligoadenylate Synthetase by the Herpes Simplex Virus Type 1 Us11 ProteinInterferon-alpha subtype 11 activates NK cells and enables control of retroviral infectionAnti-retroviral effects of type I IFN subtypes in vivoThe herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization.VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.Different antiviral effects of IFNα subtypes in a mouse model of HBV infection.Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta.Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathwayLoss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality.Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10.Potential mechanisms of interferon-alpha induced autoimmunity.Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilizationHerpes simplex virus type 2-mediated disease is reduced in mice lacking RNase LCXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous systemEffect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection.IFN-α subtypes: distinct biological activities in anti-viral therapy.Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice.Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways.CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response.Interferons as biomarkers and effectors: lessons learned from animal models.Suppression of the interferon-mediated innate immune response by pseudorabies virus.Altered gene expression and increased bursting activity of colonic smooth muscle ATP-sensitive K+ channels in experimental colitis.Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis.Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection.Distinct antiviral activities of IFN-α subtypes.
P2860
Q24815062-620C59B0-9EF7-49C3-80C2-C39BD73A0726Q27478374-D3F18E29-CD6A-4576-8F8B-962A9CD63DCEQ28482160-5D4012E3-802B-4F37-AFEF-E0C4E0B1359CQ28585391-8102EEFE-072A-4A89-8AA9-44C6E06618C0Q31036498-4D5013A9-A283-4D7A-ADE0-7A7C31ADC51DQ33615188-460BD6F4-1430-42AA-AD15-F20D3A9ABCE7Q33671963-E1377684-9A1B-44E7-894B-A91BB6A516AEQ33767313-F83397CE-E08A-45F3-BBAE-120C4F06CAFFQ33767327-0C07ED35-085C-4241-AC6B-A231B43AEE8FQ34529742-23918132-7D36-4D09-9A6F-B4233AFEE499Q34718486-7DB16191-EBAC-4C96-B1F6-8A25FC09808FQ35062414-C720BC47-9FE0-41AF-B14B-BC76CFF6094DQ35675531-0E994996-199D-40AA-A6D2-C83B08A12BEEQ35785221-543FA251-23DA-464A-8B72-13D87402A3AAQ35809335-549EAE10-EC02-4739-AC32-FFF2D14F0481Q36343355-F69216A4-E40D-48F7-B510-D8A236E2D0A3Q36464696-C4FAABF6-3F00-4702-8817-E1BF613D1825Q36675798-3F42E9E1-ABE9-4613-92E2-09D7F5760524Q36730005-814024A6-BEB4-4148-8403-6D5416118802Q36933918-9DE5FD35-6987-4C5A-BAD2-4447157B4760Q37061759-33ADE8D3-6034-4927-8A35-8E8D0EFF2353Q37333899-A66C7563-A100-4D9C-A7CF-0A90864E4DF8Q37945174-6A129F7E-F50C-4BAF-A967-4427F669DF17Q37997045-DD5E8347-5D33-4BF8-8DB4-D5D6159E67D1Q40267826-2DC11B48-C097-489D-BE84-7E1CE2FADA52Q44764152-D986BE3C-E764-495F-9334-A0D64B5149CEQ45874274-9E18BC35-D04C-4177-84DD-9FDFC22A7E06Q45889341-1CC9A34A-2882-4D7D-888A-A9F4C6F9AF8BQ54574669-B3841777-486F-4FB5-9615-8A8EDB62B9BD
P2860
Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Differential effect of murine ...... plex virus type 1 replication.
@en
Differential effect of murine ...... plex virus type 1 replication.
@nl
type
label
Differential effect of murine ...... plex virus type 1 replication.
@en
Differential effect of murine ...... plex virus type 1 replication.
@nl
prefLabel
Differential effect of murine ...... plex virus type 1 replication.
@en
Differential effect of murine ...... plex virus type 1 replication.
@nl
P2093
P2860
P1433
P1476
Differential effect of murine ...... plex virus type 1 replication.
@en
P2093
Bryan R G Williams
Cassandra James
Daniel J J Carr
Martin-Paul Agbaga
Peter Härle
Vanessa Cull
P2860
P304
P356
10.1128/JVI.76.13.6558-6567.2002
P407
P577
2002-07-01T00:00:00Z